secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2021-10-19T23:59:59+00:00
Accession:  0001493152-21-025784
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics closes $7.9M public offering, uplists to Nasdaq Capital Market
-----------------------------------------------------------------------------

- Completed public offering of 1,510,455 units at $5.25/unit for gross proceeds of $7.9M.
- Each unit consists of one share of common stock and one warrant (exercise $6.30, 5-year term).
- Warrants are immediately exercisable; underwriter has 45-day option for up to 226,568 additional shares/warrants.
- Company effectuated a 1-for-2.5 reverse stock split effective Oct 12, 2021.
- Shares and warrants began trading on Nasdaq Capital Market on Oct 13, 2021 under BBLG and BBLGW.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315221025784/0001493152-21-025784-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315221025784/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-025784

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer